Management of failures of first line treatments

Digestive and Liver Disease

Volumn 40, Issue 5, 2008, Pages 343-347

  Bureau, C ^a   Vinel, J P ^a  

^a CHU PURPAN   (France)

Author keywords

Band ligation; Beta blockers; Digestive bleeding; Esophageal varices; Portal hypertension; TIPS

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOSORBIDE MONONITRATE;

CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG TREATMENT FAILURE; ENDOSCOPIC THERAPY; ESOPHAGUS VARICES BLEEDING; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MONOTHERAPY; PATIENT COMPLIANCE; PORTAL HYPERTENSION; RECURRENT DISEASE; SCLEROTHERAPY; SHORT SURVEY; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; VEIN LIGATION;

ANTIHYPERTENSIVE AGENTS; COAGULANTS; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HUMANS; HYPERTENSION, PORTAL; LIGATION; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RECURRENCE; SCLEROTHERAPY; TREATMENT FAILURE; VASOCONSTRICTOR AGENTS;

EID: 41849109088     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.02.014     Document Type: Short Survey

References (47)

1. D'Amico G., De Franchis R., and A Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 38 (2003) 599-612
2. De Franchis R., and Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 5 (2001) 645-663
3. D'Amico G., Pagliaro L., and Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 22 (1995) 332-353
4. Infante-Rivard C., Esnaola S., and Villeneuve J.P. Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: a meta-analysis. Gastroenterology 96 (1989) 1087-1092
5. Korula J., Chin K., Ko Y., and Yamada S. Demonstration of two distinct subsets of gastric varices observed during a 7 year study of endoscopic sclerotherapy. Dig Dis Sci 36 (1991) 303-307
6. Sarin S.K., Lahoti D., Saxena S.P., Murthy N.S., and Makwana U.K. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 16 (1992) 1343-1349
7. De Franchis R. What have we accomplished?. In: De Franchis R. (Ed). Portal hypertension. III. Proceedings of the third Baveno international consensus workshop on definitions, methodology and therapeutic strategies (2001), Blackwell Science, Oxford 1-12
8. Burrougs A.K., Bosch J., Garcia-Tsao G., Henderson M., Laine L., Nevens F., et al. Definition of key events: let's try again. In: De Franchis R. (Ed). Portal hypertension. III. Proceedings of the third Baveno international consensus workshop on definitions, methodology and therapeutic strategies (2001), Blackwell Science, Oxford 13-21
9. Burroughs A.K., Calès P., Kravetz D., Riggio O., Thabut D., Van Buuren H.R., et al. Definition of key events-last attempt?. In: De Franchis R. (Ed). Portal hypertension. IV. Proceedings of the fourth Baveno international consensus workshop on methodology of diagnosis and treatment (2006), Blackwell Publishing 11-37
10. Ingrand P, Gournay J, Bernard P, Oberti F, Bernard-Chabert B, Pauwels A, et al., Management of digestive bleeding related to portal hypertension in cirrhotic patients: a French multicenter cross-sectional practice survey. World J Gastroenterol 2006;12:7810-4.
11. Lo G.H., Lai K.H., Cheng J.S., Chen M.H., Huang H.C., Hsu P.I., et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology 32 (2000) 461-465 2006;12:7810-4
12. de la Peña J., Brullet E., Sanchez-Hernandez E., Rivero M., Vergara M., Martin-Lorente J.L., et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology 41 (2005) 572-578
13. Perino L., Gholson C., and Goff J. Esophageal perforation following fiberoptic variceal sclerotherapy. J Clin Gastroenterol 9 (1987) 286-288
14. Stiegmann G.V., Goff J.S., Michaletz-Onody P.A., Korula J., Lieberman D., Saeed Z.A., et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 326 (1992) 1527-1532
15. Grace N.D., Groszmann R.J., Garcia-Tsao G., Burroughs A.K., Pagliaro L., Makuch R.W., et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 28 (1998) 868-880
16. Lebrec D., and Stiegmann GV. Prevention of recurrent variceal hemorrhage (secondary prophylaxis). In: De Franchis R. (Ed). Portal hypertension. III. Proceedings of the third Baveno international consensus workshop on definitions, methodology and therapeutic strategies (2001), Blackwell Science, Oxford 170-178
17. Viallet A., Marleau D., Huet M., Martin F., Farley A., Villeneuve J.P., et al. Hemodynamic evaluation of patients with intrahepatic portal hypertension. Gastroenterology 69 (1975) 1297-1300
18. Grozsmann R.J., Bosch J., Grace N.D., Conne H.O., Garcia-Tsao G., Navasa M., et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 99 (1990) 1401-1407
19. Villanueva C., Balanzo J., Novella M.T., Soriano G., Sainz S., Torras X., et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med 334 (1996) 1624-1629
20. Merkel C., Bolognesi M., Sacerdoti D., Bombonato G., Bellini B., Bighin R., et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 32 (2000) 930-934
21. Bureau C., Péron J.M., Alric L., Morales J., Sanchez J., Barange K., et al. "A la carte" treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology 36 (2002) 1361-1366
22. Merkel C., Sacerdoti D., Bolognesi M., Enzo E., Marin R., Bombonato G., et al. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone. Hepatology 26 (1997) 34-39
23. Cabrera J., Maynar M., Granados R., Gorriz E., Reyes R., Pulido-Duque J.M., et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 110 (1996) 832-839
24. Sanyal A.J., Freedman A.M., Velimir A., Purdum III P.P., Shiffman M.L., Cole P.E., et al. Transjugular intrahepatic portosystemic shunt compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage: a randomized controlled trial. Ann Intern Med 126 (1997) 849-857
25. Cello J.P., Ring E.J., Olcott E.W., Koch J., Gordon E., Sandhu J., et al. Endoscopic sclerotherapy compared with percutaneaous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage: a randomized controlled trial. Ann Intern Med 126 (1997) 858-865
26. Merli M., Salerno F., Riggio O., de Franchis R., Fiaccadori F., Meddi P., et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Hepatology 27 (1998) 40-45
27. Garcia-Villareal L., Martinez-Lagares F., Sierra A., Guevara C., Marrero J.M., Jimenez E., et al. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. Hepatology 29 (1999) 27-32
28. Narahara Y., Kanazawa H., Kawamata H., Tada N., Saitoh H., Matsuzaka S., et al. A randomized clinical trial comparing transjugular intrahepatic portosystemic shunt with endoscopic sclerotherapy in the long-term management of patients with cirrhosis after recent variceal hemorrhage. Hepatol Res 21 (2001) 189-198
29. Jalan R., Forrest E.H., Stanley A.J., Redhead D.N., Forbes J., Dillon J.F., et al. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology 26 (1997) 1115-1122
30. Pomier-Layrargues G., Villeneuve J.P., Deschenes M., Bui B., Perreault P., Fenyves D., et al. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut 48 (2001) 390-396
31. Gülberg V., Schepke M., Geigenberger G., Holl J., Brensing K.A., Waggershauser T., et al. Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial. Scand J Gastroenterol 37 (2002) 338-343
32. Groupe d'Etude des Anastomoses Intra-Hépatiques. TIPS vs sclerotherapy + propranolol in the prevention of variceal rebleeding: preliminary results of a multicenter randomized trial. Hepatology 22 (1995) A297 [abstract]
33. Rössle M., Deibert P., Haag K., Ochs A., Olschweski M., Siegerstetter V., et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 249 (1997) 1043-1049
34. Sauer P., Theilmann L., Stremmel W., Benz C., Richter G.M., and Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for rebleeding. Gastroenterology 113 (1997) 1623-1631
35. Sauer P., Hansmann J., Richter G.M., Stremmel W., and Stiehl A. Endoscopic variceal ligation plus propranolol vs transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. Endoscopy 34 (2002) 690-697
36. Escorsell A., Banares R., Garcia-Pagan J.C., Gilabert R., Mointinho E., Piqueras B., et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 35 (2002) 385-392
37. Papatheodoridis G.V., Goulis J., Leandro G., Patch D., and Burroughs A.K. Transjugular intrahepatic portoystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis. Hepatology 30 (1999) 612-622
38. Luca A., D'Amico G., La Galla R., Midiri M., Morabito A., and Pagliaro L. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 212 (1999) 411-421
39. Burroughs A.K., and Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis. Scand J Gastroenterol 37 (2002) 249-252
40. Rosemurgy A.S., Bloomston M., Clark W.C., Thometz D.P., and Zervos E. H-graft portacaval shunts versus TIPS. Ten-year follow-up of a randomized trial with comparison to predicted survivals. Ann Surg 241 (1997) 238-246
41. Henderson J.M., Boyer T.D., Kutner M.H., Galloway J.R., Rikkers L.F., Jeffers L.J., et al. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology 130 (2006) 1643-1651
42. Ducoin H., El-Khoury J., Rousseau H., Barange K., Peron J., Pierragi M., et al. Histopathologic analysis of transjugular intrahepatic portosystemic shunts. Hepatology 25 (1997) 1064-1069
43. Bureau C., Garcia-Pagan J.C., Otal P., Pomier-Layrargues G., Chabbert V., Cortez C., et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 126 (2004) 469-475
44. Bureau C., Pagan J.C., Pomier-Layrargues G., Métivier S., Bellot P., Perreault P., et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicenter study. Liver Int 27 (2007) 742-747
45. Rubenstein J.H., Eisen G.M., and Inadomi J.M. A cost-utility analysis of secondary prophylaxis for variceal hemorrhage. Am J Gastroenterol 99 (2004) 1274-1288
46. Russo M.W., Zacks S.L., Sandler R.S., and Brown R.S. Cost-effectiveness analysis of transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic therapy for the prevention of recurrent esophageal variceal bleeding. Hepatology 31 (2000) 358-363
47. Boyer TD, Henderson JM, Heerey AM, Arrigain S, Konig V, Connor J, et al. Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol 2008;48:407-14.